| RRC ID |
38535
|
| Author |
Liu Y, Liang Y, Zheng T, Yang G, Zhang X, Sun Z, Shi C, Zhao S.
|
| Title |
Inhibition of heme oxygenase-1 enhances anti-cancer effects of arsenic trioxide on glioma cells.
|
| Journal |
J Neurooncol
|
| Abstract |
We have previously reported that arsenic trioxide (ATO) could inhibit glioma growth both in vitro and in vivo, and demonstrated its potent therapeutic effects on gliomas. In this study we showed that ATO induced cell damage and heme oxygenase-1 (HO-1) expression in glioma cells via ROS generation. HO-1 inducer clearly protected from ATO-induced cell death and ROS generation, and HO-1 inhibitor led to a significant increase in cell death and ROS generation induced by ATO. In addition, knockdown of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) strongly inhibited HO-1 expression induced by ATO, and significantly enhanced ATO-induced oxidative damage. Our results demonstrated, for the first time, that HO-1 inhibition or Nrf2 knockdown significantly potentiated ATO's effects on glioma cells. Considering that HO-1 is highly expressed in glioma tissues, administration of ATO in combination with either HO-1 inhibitor or Nrf2 knockdown may act as a new approach to the treatment of glioma.
|
| Volume |
104(2)
|
| Pages |
449-58
|
| Published |
2011-9-1
|
| DOI |
10.1007/s11060-010-0513-1
|
| PMID |
21327864
|
| MeSH |
Antineoplastic Agents / pharmacology*
Arsenic Trioxide
Arsenicals / pharmacology*
Blotting, Western
Cell Line, Tumor
Enzyme Inhibitors / pharmacology*
Gene Knockdown Techniques
Glioma / enzymology*
Heme Oxygenase-1 / antagonists & inhibitors*
Humans
NF-E2-Related Factor 2 / metabolism
Oxides / pharmacology*
Reactive Oxygen Species / metabolism
Reverse Transcriptase Polymerase Chain Reaction
|
| IF |
3.267
|
| Times Cited |
20
|
|
WOS Category
|
CLINICAL NEUROLOGY
ONCOLOGY
|
| Resource |
| Human and Animal Cells |
U251(RCB0461)
A172(RCB2530) |
